Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurocognitive Disorders, Neurodegenerative Diseases, Mental Disorders
Interventions: Tele-Savvy, Caregiving During Crisis (Educational Program); Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 110 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Farmington, Connecticut • Atlanta, Georgia

Conditions: Ovarian Cancer
Interventions: oregovomab; Drug
Lead sponsor: Unither Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 62
States / cities: Huntsville, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 54 more

Conditions: Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Interventions: Thoracic Aortic Surgery; Procedure
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years to 79 Years
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2035
U.S. locations: 16
States / cities: San Francisco, California • Iowa City, Iowa • Boston, Massachusetts + 12 more

Conditions: Post-operative Excessive Scarring
Interventions: Botulinum Toxin, Saline; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Smallpox
Interventions: IMVAMUNE®, Placebo; Biological · Other
Lead sponsor: Bavarian Nordic; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 4,005 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 34
States / cities: Birmingham, Alabama • Anaheim, California • Los Angeles, California + 31 more

Conditions: Benign Prostatic Hypertrophy
Interventions: Ozarelix, Placebo; Drug
Lead sponsor: Spectrum Pharmaceuticals, Inc; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 13
States / cities: Tucson, Arizona • Laguna Hills, California • Los Angeles, California + 10 more

Conditions: Hot Flashes
Interventions: 400mg Magnesium Glycinate BID, Placebo; Dietary Supplement · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 85 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Apathy, Stroke, Stroke Sequelae, Stroke/Brain Attack, Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic), Motivation, Abulia
Interventions: MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System; Device · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Type 2 Diabetes
Interventions: Saxagliptin, Metformin XR, Dapagliflozin, Placebo matching with Dapagliflozin, Placebo matching with Saxagliptin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 1,282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 80
States / cities: Birmingham, Alabama • Homewood, Alabama • Muscle Shoals, Alabama + 73 more

Conditions: Head and Neck Cancer, Survivorship, Caregiver Burden, Head and Neck Neoplasms
Interventions: Survivorship Needs Assessment Planning (SNAP) tool; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Type 2 Diabetes
Interventions: Diabetes Medical Nutrition Therapy (DM MNT) Pilot; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 75 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Fontana, California

Conditions: Postoperative Pain
Interventions: Ice; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: HIV, Hepatitis C, Chronic
Interventions: Nurse Case Management; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Smoking Cessation Counselling
Interventions: Free Help, Free Nicotine message, Spanish: Free help message, Spanish: Free nicotine message; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 4,171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Atrial Fibrillation
Interventions: dapagliflozin, Placebo; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Portland, Maine • Detroit, Michigan • Rochester, New York

Conditions: Maternal Psychological Distress, Perinatal Depression, Self-Regulation, Emotion
Interventions: Trauma Informed Prenatal Intervention (TPI), Prenatal Education Topics; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Constipation
Interventions: Senna+ docusate, placebo; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Postpartum Hemorrhage, Immediate
Interventions: Intrauterine balloon tamponade; Device
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Intraoperative Bleeding
Interventions: Epinephrine, Normal Saline irrigation fluid; Drug · Procedure
Lead sponsor: The Guthrie Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Sayre, Pennsylvania

Conditions: Hot Flashes
Interventions: Hypnosis, Structured Attention; Behavioral · Other
Lead sponsor: Baylor University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Waco, Texas

Conditions: Head Lice
Interventions: Summers 5% L.A.; Drug
Lead sponsor: Summers Laboratories; Industry
Eligibility: 6 Months and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 5
States / cities: Miami, Florida • Council Bluffs, Iowa • Cincinnati, Ohio + 2 more

Conditions: Foetal Exposure During Pregnancy
Interventions: Electronic SBI; Behavioral
Lead sponsor: Public Health Institute, California; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Oakland, California • Santa Rosa, California

Conditions: Infertility
Interventions: AECC (Autologous endometrial coculture), no endometrial biopsy or Autologous endometrial coculture (AECC) performed; Procedure · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 38 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Myasthenia Gravis
Interventions: inebilizumab, IV Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 16
States / cities: Orange, California • New Haven, Connecticut • Washington D.C., District of Columbia + 13 more

Search by objective public record fields.

Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems

Clinical Trial for Ovarian Cancer (OvaRex®)

Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate

Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.

Accelerated rTMS vs. Sham for Stroke Apathy

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

KPSC MNT Pilot RCT

Ice Application for Postoperative Pain

Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection

Pragmatic Trial of Text Messages to Recruit Unassisted Tobacco Users Into Quitline Service

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity

The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery

Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage

Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery

A Mobile App for Hot Flashes and Sleep Disturbances

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.

Computerized Tool for Preventing Prenatal Drinking

Autologous Endometrial Coculture (AECCT)

Myasthenia Gravis Inebilizumab Trial